基蛋生物:欧盟地区业务收入在公司整体营业收入中占比较小

Core Viewpoint - The company,基蛋生物, is actively expanding its presence in the EU market, which, while currently a small portion of overall revenue, holds significant potential for future growth [1] Group 1: Business Strategy - The EU region contributes a minor share to the company's total revenue but is a crucial part of its international business strategy [1] - The company is enhancing its EU market development through a network of distributors, on-site customer visits, and participation in international exhibitions [1] - Future efforts will focus on advancing a global development strategy, exploring more efficient market expansion and business collaboration models while solidifying existing partnerships [1]

Getein Biotech-基蛋生物:欧盟地区业务收入在公司整体营业收入中占比较小 - Reportify